Elucidation of the pathogenesis of coronary microvascular disease in hypertrophic cardiomyopathy

Elucidation of the pathogenesis of coronary microvascular disease in hypertrophic cardiomyopathy - Elucidation of the pathogenesis of coronary microvascular disease in hypertrophic cardiomyopathy

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000051656

Enrollment

Registered

2023-07-20

Start date

2023-07-20

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Hypertrophic cardiomyopathy

Interventions

cardiac catheterization

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Patients diagnosed with hypertrophic cardiomyopathy and undergoing cardiac catheterization in routine practice.

Exclusion criteria

Exclusion criteria: Patients who did not give consent or who refused to donate.

Design outcomes

Primary

Measure	Time frame
Degree of coronary microvascular disease in hypertrophic cardiomyopathy	—

Countries

Japan

Contacts

Public ContactTerumori Sato

Hamamatsu University School of Medicine Hospital Cardiology

tesato@hama-med.ac.jp053-435-2267

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026